Scpharmaceuticals Inc.

Burlington, MA Part of Mannkind Corporation

UEI
FR6KDUV5LMT2
CAGE
73Y45
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
  • Corporate Parent Mannkind Corporation · Danbury, CT QJQAMVDWVBN8
    • Scpharmaceuticals Inc.
SAM.gov registration date
Physical address
25 Burlington Mall Road #203, Burlington, MA 01803, USA
Founded
1991
Employees
51-250
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $7,237
FY2023 $7,239

Contract vehicles

Contract awards

Similar vendors

About the company

Scpharmaceuticals Inc. is a for-profit corporate entity based in Lexington, MA that develops innovative therapeutics that can be delivered subcutaneously via an on-body infusor, including furosemide for heart failure diuresis and treatments for bacterial infections. The company has been registered in the System for Award Management (SAM) to receive federal awards since 2014.

Scpharmaceuticals Inc. has recently been awarded several federal contracts to provide pharmaceutical products, primarily the company's FUROSCIX furosemide medication, to the Department of Veterans Affairs (VA) Veterans Health Administration. In November 2023, the VA VISN 9 issued a $7,237 purchase order for emergency furosemide supplies to the Nashville VA Medical Center. In August 2023, VA VISN 9 awarded another $7,239 purchase order for FUROSCIX furosemide body kits to be delivered from Haverhill, MA. These firm-fixed-price contracts were not set aside and did not involve any subcontractors.

Scpharmaceuticals Inc. has also been awarded multiple Federal Supply Schedule (FSS) indefinite-delivery, indefinite-quantity contracts by VA VHA VISN 12. In November 2023, the company received a $600,875 FSS 65 IB contract to provide drugs, pharmaceuticals, and hematology-related products through November 2028. This multiple-award vehicle establishes pricing for 65 IB products that can be ordered by VA facilities over the next 5 years. Additionally, in June 2023, Scpharmaceuticals Inc. was awarded a $25,000 interim FSS 65 IB agreement to provide pharmaceuticals and supplies pending the larger contract award.

Quick answers

Is Scpharmaceuticals Inc. registered in SAM.gov?

Yes. Scpharmaceuticals Inc.'s SAM.gov registration is active through January 14, 2027.

What is Scpharmaceuticals Inc.'s CAGE code?

Scpharmaceuticals Inc.'s CAGE code is 73Y45, and its Unique Entity ID (UEI) is FR6KDUV5LMT2.

Which contract vehicles does Scpharmaceuticals Inc. hold?

Scpharmaceuticals Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.

How much has Scpharmaceuticals Inc. received in federal contracts?

Federal contracts obligated $14,476 to Scpharmaceuticals Inc. in fiscal years 2023 through 2027.

What is Scpharmaceuticals Inc.'s most recent federal award?

Scpharmaceuticals Inc.'s most recent federal contract award is Emerg. Furoscix for the boro VAMC pharm 37129 (36C24924P0138), from Veterans Integrated Service Network 9 (VHA), on November 9, 2023.

On GovTribe

See Scpharmaceuticals Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe